Brief: Aker Biomarine Secures FDA Approval For QRILL Aqua In US
June 15 (Reuters) - Aker Biomarine ASA AKBM.OL :
* SECURES FDA APPROVAL FOR QRILL AQUA IN UNITED STATES
* HAS RECEIVED APPROVAL FROM FDA FOR USE OF ITS QRILL AQUA
AND
QRILL HIGH PROTEIN (QHP) PRODUCTS IN FRESHWATER AND MARINE
SALMONIDS
Further company coverage: AKBM.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Aker Biomarine ASA
See all newsBrief: Aker Biomarine Secures Lysoveta Contract
Norway's Aker BioMarine Q1 revenue rises 13% on record krill oil sales
Brief: Aker Biomarine Q1 Adjusted EBITDA $12.5 Mln
Norway's Aker BioMarine exploring alternatives for Human Health Ingredient unit
Brief: Aker BioMarine Q4 Adjusted EBITDA USD 10.6 Million